1-16 of 16
chlorambucil
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Multicenter analysis of geriatric fitness and real-world outcomes in older patients with classical Hodgkin lymphoma

Clinical Trials & Observations
Victor M. Orellana-Noia, Krista Isaac, Mary-Kate Malecek, Nancy L. Bartlett, Timothy J. Voorhees, Natalie S. Grover, Steven R. Hwang, N. Nora Bennani, Rachel Hu, Brian T. Hill, Eric Mou, Ranjana H. Advani, Jordan Carter, Kevin A. David, Hatcher J. Ballard, Jakub Svoboda, Michael C. Churnetski, Gabriela Magarelli, Tatyana A. Feldman, Jonathon B. Cohen, Andrew M. Evens, Craig A. Portell
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3623–3632.
https://doi.org/10.1182/bloodadvances.2021004645
Published: 2021
Includes: Supplemental data
Journal Articles

Avelumab in relapsed/refractory classical Hodgkin lymphoma: phase 1b results from the JAVELIN Hodgkins trial

Clinical Trials & Observations
Alex F. Herrera, Catherine Burton, John Radford, Fiona Miall, William Townsend, Armando Santoro, Pier Luigi Zinzani, David Lewis, Camilla Fowst, Satjit Brar, Bo Huang, Aron Thall, Graham P. Collins
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3387–3396.
https://doi.org/10.1182/bloodadvances.2021004511
Published: 2021
Includes: Supplemental data
Journal Articles

The landscape of copy number variations in classical Hodgkin lymphoma: a joint KU Leuven and LYSA study on cell-free DNA

Lieselot Buedts, Iwona Wlodarska, Julio Finalet-Ferreiro, Olivier Gheysens, Luc Dehaspe, Thomas Tousseyn, Luc-Matthieu Fornecker, Julien Lazarovici, René-Olivier Casasnovas, Anne-Claire Gac, Christophe Bonnet, Kamal Bouabdallah, Christiane Copie-Bergman, Bettina Fabiani, Daan Dierickx, Lukas Marcelis, Joris Vermeesch, Marc André, Peter Vandenberghe
Journal: Blood Advances
Blood Adv (2021) 5 (7): 1991–2002.
https://doi.org/10.1182/bloodadvances.2020003039
Published: 2021
Includes: Supplemental data
Journal Articles

Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma

Alex Reza Gholiha, Peter Hollander, Ingrid Glimelius, Gustaf Hedstrom, Daniel Molin, Henrik Hjalgrim, Karin E. Smedby, Jamileh Hashemi, Rose-Marie Amini, Gunilla Enblad
Journal: Blood Advances
Blood Adv (2021) 5 (6): 1671–1681.
https://doi.org/10.1182/bloodadvances.2020003664
Published: 2021
Includes: Supplemental data
Journal Articles

The critical role of CD4 + T cells in PD-1 blockade against MHC-II–expressing tumors such as classic Hodgkin lymphoma

Joji Nagasaki, Yosuke Togashi, Takeaki Sugawara, Makiko Itami, Nobuhiko Yamauchi, Junichiro Yuda, Masato Sugano, Yuuki Ohara, Yosuke Minami, Hirohisa Nakamae, Masayuki Hino, Masahiro Takeuchi, Hiroyoshi Nishikawa
Journal: Blood Advances
Blood Adv (2020) 4 (17): 4069–4082.
https://doi.org/10.1182/bloodadvances.2020002098
Published: 2020
Includes: Supplemental data
Journal Articles

KEYNOTE-013 4-year follow-up of pembrolizumab in classical Hodgkin lymphoma after brentuximab vedotin failure

Clinical Trials & Observations
Philippe Armand, John Kuruvilla, Jean-Marie Michot, Vincent Ribrag, Pier Luigi Zinzani, Ying Zhu, Patricia Marinello, Akash Nahar, Craig H. Moskowitz
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2617–2622.
https://doi.org/10.1182/bloodadvances.2019001367
Published: 2020
Includes: Supplemental data
Journal Articles

Gene expression profiling of gray zone lymphoma

Clémentine Sarkozy, Lauren Chong, Katsuyoshi Takata, Elizabeth A. Chavez, Tomoko Miyata-Takata, Gerben Duns, Adèle Telenius, Merrill Boyle, Graham W. Slack, Camille Laurent, Pedro Farinha, Thierry J. Molina, Christiane Copie-Bergman, Diane Damotte, Gilles A. Salles, Anja Mottok, Kerry J. Savage, David W. Scott, Alexandra Traverse-Glehen, Christian Steidl
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2523–2535.
https://doi.org/10.1182/bloodadvances.2020001923
Published: 2020
Includes: Supplemental data
Journal Articles

Five-year results of the BEGEV salvage regimen in relapsed/refractory classical Hodgkin lymphoma

Clinical Trials & Observations
Armando Santoro, Rita Mazza, Alessandro Pulsoni, Alessandro Re, Maurizio Bonfichi, Vittorio Ruggero Zilioli, Manuela Zanni, Francesco Merli, Antonella Anastasia, Stefano Luminari, Giorgia Annechini, Manuel Gotti, Annalisa Peli, Anna Marina Liberati, Nicola Di Renzo, Luca Castagna, Laura Giordano, Francesca Ricci, Carmelo Carlo-Stella
Journal: Blood Advances
Blood Adv (2020) 4 (1): 136–140.
https://doi.org/10.1182/bloodadvances.2019000984
Published: 2020
Includes: Supplemental data
Journal Articles

Trends in postrelapse survival in classic Hodgkin lymphoma patients after experiencing therapy failure following auto-HCT

Clinical Trials & Observations
Talha Badar, Narendranath Epperla, Aniko Szabo, Steven Borson, John Vaughn, Gemlyn George, Neeraj Saini, Abdul Rashid Shah, Romil D. Patel, Sairah Ahmed, Nirav N. Shah, Amanda F. Cashen, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood Advances
Blood Adv (2020) 4 (1): 47–54.
https://doi.org/10.1182/bloodadvances.2019000736
Published: 2020
Journal Articles

Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion

Kirsty Wienand, Bjoern Chapuy, Chip Stewart, Andrew J. Dunford, David Wu, Jaegil Kim, Atanas Kamburov, Timothy R. Wood, Fathima Zumla Cader, Matthew D. Ducar, Aaron R. Thorner, Anwesha Nag, Alexander T. Heubeck, Michael J. Buonopane, Robert A. Redd, Kamil Bojarczuk, Lee N. Lawton, Philippe Armand, Scott J. Rodig, Jonathan R. Fromm, Gad Getz, Margaret A. Shipp
Journal: Blood Advances
Blood Adv (2019) 3 (23): 4065–4080.
https://doi.org/10.1182/bloodadvances.2019001012
Published: 2019
Includes: Supplemental data
Journal Articles

Brentuximab vedotin followed by bendamustine supercharge for refractory or relapsed Hodgkin lymphoma

Clinical Trials & Observations
M. Picardi, R. Della Pepa, C. Giordano, N. Pugliese, C. Mortaruolo, F. Trastulli, M. G. Rascato, I. Cappuccio, M. Raimondo, M. Memoli, M. Monteverde, M. Mascolo, F. Pane
Journal: Blood Advances
Blood Adv (2019) 3 (9): 1546–1552.
https://doi.org/10.1182/bloodadvances.2019000123
Published: 2019
Journal Articles

Cost-effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia in older adults without deletion 17p

James I. Barnes, Vasu Divi, Adrian Begaye, Russell Wong, Steven Coutre, Douglas K. Owens, Jeremy D. Goldhaber-Fiebert
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1946–1956.
https://doi.org/10.1182/bloodadvances.2017015461
Published: 2018
Includes: Supplemental data
Journal Articles

CXCR5 and ICOS expression identifies a CD8 T-cell subset with T FH features in Hodgkin lymphomas

Kieu-Suong Le, Patricia Amé-Thomas, Karin Tarte, Françoise Gondois-Rey, Samuel Granjeaud, Florence Orlanducci, Etienne D. Foucher, Florence Broussais, Reda Bouabdallah, Thierry Fest, Dominique Leroux, Sapna Yadavilli, Patrick A. Mayes, Luc Xerri, Daniel Olive
Journal: Blood Advances
Blood Adv (2018) 2 (15): 1889–1900.
https://doi.org/10.1182/bloodadvances.2018017244
Published: 2018
Includes: Supplemental data
Journal Articles

Checkpoint blockade in Hodgkin and non-Hodgkin lymphoma

Reid W. Merryman, Philippe Armand, Kyle T. Wright, Scott J. Rodig
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2643–2654.
https://doi.org/10.1182/bloodadvances.2017012534
Published: 2017
Journal Articles

Clinicopathologic consensus study of gray zone lymphoma with features intermediate between DLBCL and classical HL

Clinical Trials & Observations
Monika Pilichowska, Stefania Pittaluga, Judith A. Ferry, Jessica Hemminger, Hong Chang, Jennifer A. Kanakry, Laurie H. Sehn, Tatyana Feldman, Jeremy S. Abramson, Athena Kritharis, Francisco J. Hernandez-Ilizaliturri, Izidore S. Lossos, Oliver W. Press, Timothy S. Fenske, Jonathan W. Friedberg, Julie M. Vose, Kristie A. Blum, Deepa Jagadeesh, Bruce Woda, Gaurav K. Gupta, Randy D. Gascoyne, Elaine S. Jaffe, Andrew M. Evens
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2600–2609.
https://doi.org/10.1182/bloodadvances.2017009472
Published: 2017
Includes: Supplemental data
Journal Articles

High proportions of PD-1 + and PD-L1 + leukocytes in classical Hodgkin lymphoma microenvironment are associated with inferior outcome

Clinical Trials & Observations
Peter Hollander, Peter Kamper, Karin Ekstrom Smedby, Gunilla Enblad, Maja Ludvigsen, Julie Mortensen, Rose-Marie Amini, Stephen Hamilton-Dutoit, Francesco d’Amore, Daniel Molin, Ingrid Glimelius
Journal: Blood Advances
Blood Adv (2017) 1 (18): 1427–1439.
https://doi.org/10.1182/bloodadvances.2017006346
Published: 2017
Includes: Supplemental data